Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    • News

  • Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    • News

  • Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    • News

  • European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    • News

  • Harris Technology’s refurbished boom signals FY26 profit inflection
    Harris Technology’s refurbished boom signals FY26 profit inflection
    • News

Do you really own your shares?

  • In Opinion
  • April 27, 2021
  • Samantha Freidin
Do you really own your shares?

The global pandemic affected almost every aspect of modern life, and the stock market was no exception. The stock market crash early in 2020 saw an influx of retail investors and a huge increase in the number of accounts opened on trading apps. While investing is almost always a positive step towards financial freedom, experts are concerned that inexperienced retail investors are flocking to apps without fully understanding their custody structure and risk involved.

What is a custodial account?

Simply put, a custodial account is a brokerage account with a nominee company for investing in shares. You don’t technically own the shares you invest in. The nominee company (or custodian) holds securities in their own name, on behalf of the actual investors.

Custodians can organise dividend and interest payment collection and distribution, transaction processing, tax reporting and brokerage account administration.

Wait, what do you mean I don’t own the shares?

When you buy shares through a traditional broker, you receive a Holder Identification Number (HIN) that is registered with the stock exchange registry. You own these shares directly in your name. Custodial accounts have their own HIN and own the shares. When you ‘purchase’ a share through a custodial account you are becoming the beneficial owner of the share, and entitled  to any dividends that share will pay and the economic value it will hold.

Ok, so what’s the catch with custodial accounts?

Not owning your shares directly can open you up to another layer of risk. If the nominee company that holds your shares goes bankrupt or ceases to exist for some reason you will have to compete with others who have a claim to the nominee company’s assets, their shares. By trading through a nominee company you are assuming this risk with a counterparty.

What might happen if a nominee company goes broke?

In 2011, following the global financial crisis, major brokerage firm MF Global went bankrupt. Customer losses were as high as $1.6 billion. Two years after liquidation the company was approved for settlement that would return only 93% of their customers’ investments.

Only 93%.

Customers had to wait years to access their hard earned money and even then, couldn’t access all of it.

Other examples of pooled assets in custodial structures to fail were Sonray in 2011 (Shares, CFDs – $47m loss), Halifax in 2019 (Shares, CFDs – approx $33m loss), BBY Stockbroker in 2015 (Shares, Derivatives, CFDs – approx $40m loss). Interestingly, the trustee of Halifax’s preferential shares, Australian Executor Trustees (AET), was owned by IOOF. AET was sold to Sargon Capital Pty Ltd, with the Sargon Group entities collapsing in January 2020.

Are there any benefits to custodial accounts?

Yes! Nominee companies pool investors money together which means that they can offer cheaper brokerage fees than traditional stock brokers.

Some nominee companies also give investors the option of fractionalising a share, meaning investors are able to diversify their portfolios and access stocks they may otherwise be unable to afford. Foreign share markets are also available through most custodial accounts in Australia.

How do I check my broker’s custody structure?

Brokers will provide details on their custody structure in a Product Disclosure Statement and their Financial Services Guide, these are usually available via their website.

Final thoughts

Whether you use a HIN or custodial account is of course, up to you and your level of risk tolerance. Longer term investors managing a large portfolio tend to ensure they directly own their shares via a HIN, whilst day traders making frequent trades tend to prefer the cheaper offering of a custodial account.

Something you hear a lot in this industry is the phrase ‘you get what you pay for’ and that’s definitely the case here. The peace of mind that your capital is safe can be worth more than super cheap $5 brokerage.

Check out the infographic below for more info around the rise of retail investors and use of custodial accounts. Find out more about TradersCircle’s trading and stock market education services by clicking here.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  •  
  •  
  •  
  •  
  • Opinion

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.